Hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Previous hypertension group inclusion criteria: hypertensive patients who had participated in the 2021 study of "The effect of dietary quality Index on T cell subsets of rural hypertensive patients and its mechanism"; (2) Inclusion criteria for the newly diagnosed hypertension group: Participants who had participated in the "Study on the Influence of Dietary Quality Index on T cell subsets of Rural hypertensive Patients and its Mechanism" in 2021 and were classified as non-hypertensive patients, those with newly diagnosed hypertension from 2021 to 2023 were enrolled in the hypertension follow-up registration at Zhangfang Community Hospital and included in chronic disease management; (3) Previous non-hypertensive group inclusion criteria: Participated in the "Study on the Influence of Dietary Quality Index on T cell subsets of rural hypertensive Patients and its mechanism" in 2021, and were enrolled as non-hypertensive patients. So far, no non-hypertensive patients have been diagnosed with hypertension; (4) The inclusion criteria of the non-hypertensive group were supplemented: there was no clear diagnosis of hypertension and no participation in the 2021 study on the effect of dietary quality Index on T cell subsets of rural hypertensive patients and its mechanism, and non-hypertensive patients matched with newly diagnosed hypertensive patients according to gender and age. (5) Did not participate in the 2021 study on the effect of Dietary quality Index on T cell subsets of rural hypertensive patients and its mechanism, and met the requirements of hypertensive/non-hypertensive patients matched by gender, age and the 2021 survey lost access population.
Exclusion criteria
Exclusion criteria: (1) Patients with rheumatism, SLE and other immune diseases; (2) mental abnormality can not cooperate; (3) Severe liver and kidney diseases may lead to immune abnormalities; (4) physical disability can not cooperate with body measurement, body composition detection; (5) refuse to draw blood, stool sampling.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| systolic pressure;diastolic blood pressure;body composition; | — |
Secondary
| Measure | Time frame |
|---|---|
| c reactive protein;t cell subset;IL-22; | — |
Countries
China
Contacts
Beijing Friendship Hospital, Capital Medical University